Home/Investors/Information not publicly specified

Information not publicly specified

Biotech Investor · 4 portfolio companies

Portfolio
4
Focus Areas
2
Top Stage
preclinical

Investment Focus

Portfolio Companies

CompanyValuation
Nilo Therapeutics
Synnovation Therapeutics
Adcytherix
CellGen